Atypical hemolytic‐uremic syndrome after COVID‐19 vaccine: A case report

Atypical hemolytic‐uremic syndrome after COVID‐19 vaccine: A case report

Abstract Background The emergence of new SARS‐CoV‐2 variants and the global COVID‐19 pandemic spurred urgent vaccine development. While common vaccine side effects are well‐documented, rare adverse events necessitate post‐marketing surveillance. Recent research linked messenger RNA vaccines to throm...

Full description

Bibliographic Details
Main Authors: Marcos Adriano Garcia Campos, Rômullo José Costa Ataídes, Maxwell Cabral Ferreira, Adriano Soares Alves, Gyl Eanes Barros Silva
Format: Article
Language:English
Published: Wiley 2024-07-01
Series:Immunity, Inflammation and Disease
Subjects:
atypical hemolytic‐uremic syndrome
case report
post‐COVID‐19
thrombotic microangiopathy
Online Access:https://doi.org/10.1002/iid3.1270

Internet

https://doi.org/10.1002/iid3.1270

Similar Items